The Association between Lipoprotein (a) Levels and the Development of Cardiac Allograft Vasculopathy
Lipoprotein (a) has been established as an independent risk factor for cardiovascular
diseases. However, its role in cardiac allograft vasculopathy (CAV) development remains …
diseases. However, its role in cardiac allograft vasculopathy (CAV) development remains …
Transplanting the unexpected: what happens when donors have coronary artery disease?
S Pandey, A Verma, R Mehta, G Bushi… - … Journal of Surgery …, 2024 - journals.lww.com
Heart transplantation remains the definitive treatment for patients with end-stage heart
failure, significantly improving survival rates and quality of life.[1, 2] However, the demand for …
failure, significantly improving survival rates and quality of life.[1, 2] However, the demand for …